Depressive symptoms cause major impairment and may accelerate HIV progression despite the use of antiretroviral medication. The somatic symptoms criteria for HIV infection and depression partially overlap, which can make differential diagnosis challenging. Because of chronic inflammation caused by HIV infection, HIV-positive patients may develop somatic and affective-cognitive symptoms of depression. Inflammation-related depression is primarily characterized with severe somatic symptoms such as fatigue and sleep disturbance. This study sought to explore the patterns of somatic and cognitive-affective depressive symptoms that characterize HIV-positive patients. Our specific aims were (1) to identify subtypes of depressive symptoms in a sample of HIV-positive patients; and (2) to test the subtypes' difference on inflammatory and HIV disease progression biomarkers. HIV-positive men and women (N = 102) with and without depressive symptoms were randomly selected from an Italian HIV clinic. Depressive symptoms (PHQ-9), viral load (VL), CD4+, Il-6, TNF-a, and monocytes were assessed. The three subtypes formed using Latent Class Analysis (LCA) identified patients with (1) severe cognitive-affective and somatic depressive symptoms; (2) severe/moderate somatic symptoms; and (3) absent or low depressive symptoms. The subtype with severe/moderate somatic symptoms was characterized with elevated levels of Il-6 and monocytes. No difference on HIV progression biomarkers was found. The subtypes of depressive symptoms might help differentiating depressive symptoms from HIV-and inflammatory-related somatic symptoms. When present, cognitive-affective and/or somatic symptoms cause significant impairment to patients' lives and thus warrant further assessment and treatment.
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Introduction
Depression is a potentially fatal medical condition that causes major impairments and disability in the general population (Moussavi et al., 2007) . People living with chronic medical illnesses such as HIV are at a greater risk of developing depressive symptoms (Simon, 2001; Rabkin, 2008) , which ultimately affect the course of their physical illness (Chapman et al., 2005; Lépine and Briley, 2011; Antelman et al., 2007) . Depressive symptoms are highly prevalent in HIV-positive patients (Rabkin, 2008) and are associated with immune system impairment (Kaharuza et al., 2006) , poor medical care engagement and adherence to medication (Sterne et al., 2005; Horberg et al., 2008; Gonzalez et al., 2011) .
Untreated depression hastens the progression of HIV infection and increases mortality rates (Elliott et al., 2002; Lima et al., 2007) . Routine assessment of depressive symptoms using psychometric tools would allow for early diagnosis, enlisting effective treatment to improve patients' health status (Pence et al., 2012; Schumacher et al., 2013; Kalichman et al., 2000; Ferrando et al., 1998) . Assessment must consider the wide array of depressive symptoms, such as cognitive-affective (e.g., depressed mood and anhedonia) and somatic (e.g., fatigue and sleep disturbance) symptoms (Kalichman et al., 2000) . While somatic symptoms are attributable to both idiopathic depression and HIV infection, cognitive-affective symptoms are more specific to clinical depression (Kalichman et al., 2000; Barroso et al., 2013; Lee et al., 2012; Low et al., 2011) . Methods for distinguishing depression from HIV-related somatic symptoms should be employed when assessing HIV-positive patients (Kalichman et al., 2000) . However,
